ViroPharma Incorporated (VPHM)

[surf1944]

6:57AM ViroPharma files prior approval supplement for Cinryze industrial scale manufacturing (VPHM) 12.19 : Co provided an update on recent progress in Cinryze manufacturing expansion activities. ViroPharma is increasing its Cinryze manufacturing capacity through two concurrent efforts. The first project, the parallel chromatography process, was implemented earlier this year and allows production to run across multiple shifts, effectively doubling the capacity of the current manufacturing line and increasing the amount of drug supply available to patients suffering from hereditary angioedema, or HAE. The addition of the industrial scale project is expected to significantly increase capacity for Cinryze, providing adequate supply to meet the company's projected demand growth for prophylaxis against attacks of HAE.